Background {#Sec1}
==========

Atrial fibrillation (AF) is the most common clinically-significant adult arrhythmia \[[@CR1], [@CR2]\]. In 2010, 5.2 million people in the United States were estimated to have AF and a projected 12.1 million people were expected to have AF by the year 2030 \[[@CR3]\]. For individuals with AF, the most frequent cardiovascular complications include ischemic stroke, heart failure and sudden cardiac death \[[@CR4]\]. To prevent such complications, medications, including anticoagulants, are prescribed to lower the risk of ischemic stroke and other arterial thromboembolisms \[[@CR5]\]. Medications for heart rate control and/or medications for rhythm control are also routinely prescribed \[[@CR6]--[@CR8]\]. Nevertheless, adherence to such prescribed medications is suboptimal and can translate into an increased risk of treatment failure, hospitalizations and early mortality \[[@CR9]--[@CR15]\].

In addition to the potential occurrence of AF-specific complications, many patients with AF present with non-cardiovascular specific comorbidities \[[@CR16]--[@CR19]\]. One study reported that 98% of patients with AF had at least one comorbidity \[[@CR16]\]. The most commonly reported non-cardiovascular comorbidity was urologic disorders (62%) followed by chronic pain (61%), respiratory (42%), gastrointestinal (41%), sleep (29%), psychiatric (28%), cancer (26%) and dermatologic (26%) conditions. However, little is known about medication adherence to the treatment of these comorbidities and limited data exist regarding predictors of AF-specific medication non-adherence \[[@CR15], [@CR20]\]. It may be that patients with AF present as a unique sub-population among those with cardiovascular disease. According to the American Heart Association, many people with AF don't recognize the seriousness of their illness (\> 65%) \[[@CR21]\] and may be less adherent to their medication compared to those in the general cardiovascular disease population. Additionally, patients with AF may not experience symptoms \[[@CR21]\], leading to potentially lower adherence to medication. Although these instances are specific to treatments for AF, these behaviors may carry over into adherence to their other medication regimens.

It has been suggested, in studies assessing AF-specific medication adherence, that younger age may be one possible risk factor for non-adherence \[[@CR22]\], but the findings for gender \[[@CR23], [@CR24]\], socioeconomic status \[[@CR22], [@CR25]\] and comorbidities \[[@CR26], [@CR27]\] are mixed. Additionally, dementia, mental function and the complexity of the dosing regimen have been found to decrease medication adherence in patients with AF \[[@CR20], [@CR22], [@CR28]\]. Identifying those AF patients at greatest risk for general medication non-adherence remains a difficult task. To address this knowledge gap, we evaluated the associations between select patient characteristics and self-reported medication adherence within a large, ethnically diverse population of adults with incident diagnosed AF to elucidate those patients who may be at greatest risk for medication non-adherence.

Methods {#Sec2}
=======

Setting {#Sec3}
-------

Kaiser Permanente Northern California (KPNC) and Kaiser Permanente Southern California (KPSC) are two integrated healthcare delivery systems that currently provide comprehensive care to over 8 million individuals throughout the state of California. These \> 8 million individuals represent a socio-demographically diverse population that is highly characteristic of the statewide population \[[@CR29]--[@CR31]\]. Complete details of the healthcare services that these individuals receive are captured through structured administrative and clinical databases managed through the EpicCare system (Epic Systems, Verona, WI).

Study population {#Sec4}
----------------

The present investigation included KPNC and KPSC members who were part of the Anticoagulation and Risk Factors in Atrial Fibrillation -- Cardiovascular Research Network (ATRIA-CVRN) cohort \[[@CR32]\]. Details of this cohort have been previously described \[[@CR1], [@CR32]--[@CR35]\]. In short, patients 21 years of age or older who were diagnosed with incident AF or atrial flutter between January 1, 2006 and June 30, 2009 were included (Fig. [1](#Fig1){ref-type="fig"}). Of these patients, a subset completed a 35-item health questionnaire. Questionnaire data were available from 13,140 patients with the median length of time between cohort entry and questionnaire completion being 2.65 years. Patients missing responses to the questions on medication adherence (*n* = 981) were excluded, leaving 12,159 patients for analysis. This study was approved by the ethics committees at Kaiser Permanente Northern and Southern California (reference numbers CN-09AGo-14-H and 5572, respectively). A waiver of written informed consent was obtained due to the nature of the study being a minimal-risk health questionnaire.Fig. 1Assembly of the adult atrial fibrillation cohort with complete health questionnaire data to assess medication adherence status (*n* = 12,159)

Medication adherence {#Sec5}
--------------------

Medication adherence was assessed using three questions adapted from the Coronary Artery Risk Development in Young Adults (CARDIA) study \[[@CR36]\]: (1) 'In the past month, how often did you take your medications as the doctor prescribed?' with the response options of 'All of the time (100%)', 'Nearly all of the time (90%)', 'Most of the time (75%)', 'About half the time (50%)' and 'Less than half the time (\<50%)'; (2) 'In the past month, how often did you forget to take one or more of your prescribed medications?' with the response options of 'Never', 'Once', '2--3 times', 'Once per week', 'Several times per week' and 'Nearly every day'; and (3) 'In the past month, how often did you decide to skip one or more of your prescribed mediations' with the same response options as question two. Medication non-adherence was defined as either (a) response to question one of "most of the time (75%)" or less, (b) response to question two of "once per week" or more, or (c) response to question three of "once per week" or more, based on previously validated definitions of non-adherence \[[@CR37]\].

Patient characteristics {#Sec6}
-----------------------

Age and sex were determined from the patient's electronic health record (EHR) at the time of AF diagnosis. Socio-demographic characteristics including race/ethnicity, marital status, educational attainment, and household income were obtained by questionnaire. Physical activity (based on frequency, duration and intensity of activity in the past month) and height, weight, cigarette, alcohol and aspirin use during the year prior were also obtained by questionnaire. Height and weight were used to calculate body mass index (BMI kg/m^2^). Self-reported health status was also collected from the questionnaire to evaluate frequency of poor physical and mental health in the past month prior to questionnaire completion (range: 0 to 30 days), overall current health (range: poor to excellent), if sleep was affecting daily function (range: never to almost every day), memory decline and health literacy (based on a validated 3-item instrument examining problems due to reading, understanding and completing medical forms dichotomized into adequate or inadequate \[[@CR38]--[@CR41]\]).

History of coronary heart disease, chronic heart failure, dementia, depression, diabetes mellitus, hypertension, ischemic stroke and transient ischemic attack were extracted from the EHRs using ICD-9-CM codes obtained from both inpatient and outpatient encounters during the 5-year period prior to questionnaire completion. These data were used to calculate a CHADS~2~ stroke risk score \[[@CR26]\]. A Charlson Comorbidity Index (CCI) score was also calculated using ICD-9-CM codes from both inpatient and outpatient encounters during the 1-year period prior to questionnaire completion, to account for overall comorbidity burden and risk of mortality \[[@CR42]\].

Statistical analysis {#Sec7}
--------------------

Socio-demographic characteristics, health behaviors, self-reported health status and medical history were compared across medication adherence status using chi-square, Fisher's exact and Wilcoxon signed-rank tests, as appropriate. Adjusted odds ratios (ORs) and 95% confidence intervals (CIs) for non-adherence were estimated using multivariable logistic regression models among all patients with complete questionnaire data, with all patient characteristics available in the survey included as candidate predictors. All analyses were conducted using SAS software version 9.2 (SAS Institute, Cary, NC).

Results {#Sec8}
=======

Of the 12,159 patients with incident diagnosed AF who responded to the questionnaire items regarding medication adherence, 771 (6.3%) were categorized as not adherent to their prescribed medications (Table [1](#Tab1){ref-type="table"}). Patients who self-reported non-adherence to prescribed medications were younger (\< 65 years of age) and more likely to be a racial/ethnic minority, not married or living with a partner and have a household income of \$25,000 or less compared to those who were adherent (Table [2](#Tab2){ref-type="table"}). Non-adherent patients were also more likely to report less physical activity, be a current smoker and consume alcohol. In addition, non-adherent patients were more likely to self-report more than 1 day of poor physical and/or mental health in the last month, have fair or poor current overall health, indicate that sleep affected their daily function more than 1 day a week, have memory decline in the past 2--3 years and have inadequate health literacy compared to those patients who were adherent. Lastly, non-adherent patients were less likely to have hypertension, but more likely to report low-dose aspirin use in the last year, have a BMI ≥30, CHADS~2~ score of 0, depression and diabetes mellitus compared to adherent patients. Most univariate associations were retained in the multivariable model, with a few exceptions (Table [3](#Tab3){ref-type="table"}). In particular, household income, cigarette use, self-rated current health, BMI and depression status were not statistically significant independent correlates of medication non-adherence. However, having a CCI score ≥ 3 was associated with a decreased adjusted odds of medication non-adherence, after accounting for other patient characteristics.Table 1Responses to medication adherence questions from 12,159 incident atrial fibrillation patientsn (%)Question1. In the past month, how often did you take your medications as the doctor prescribed? All of the time (100%)10,120 (83.2) Nearly all of the time (90%)1726 (14.2) Most of the time (75%)202 (1.7) About half the time (50%)37 (0.3) Less than half the time (\<50%)74 (0.6)2. In the past month, how often did you forget to take one or more prescribed medications? Never7147 (58.8) Once3061 (25.2) 2--3 times1551 (12.8) Once per week281 (2.3) Several times per week73 (0.6) Nearly every day46 (0.4)3. In the past month, how often did you decide to skip one or more prescribed medications? Never10,599 (87.2) Once734 (6.0) 2--3 times505 (4.2) Once per week117 (1.0) Several times per week96 (0.8) Nearly every day108 (0.9)Medication Adherence Adherent11,388 (93.7) Not Adherent^a^771 (6.3)^a^Not adherent defined as (a) an answer to question 1 as "most of the time (75%)" or less or (b) an answer to question 2 as "once per week" or more or (c) an answer to question 3 as "once per week" or moreTable 2Characteristics of 12,159 incident atrial fibrillation patients by medication adherence statusAdherent\
*n* = 11,388\
(93.7%)Not Adherent\
*n* = 771\
(6.3%)P^†^Socio-demographicsAge, years\< 0.001 Median72.770.1 25th -- 75th %64.4--79.959.5--79.1Age group, years, n (%)\< 0.001  \< 653017 (26.5)293 (38.0) 65--743549 (31.2)198 (25.7) 75--843523 (30.9)185 (24.0)  ≥ 851299 (11.4)95 (12.3)Male, n (%)6498 (57.1)435 (56.4)0.735Race/Ethnicity, n (%)\< 0.001 Non-Hispanic White8505 (74.7)502 (65.1) Non-Hispanic Black572 (5.0)81 (10.5) Non-Hispanic Asian/Pacific Islander775 (6.8)64 (8.3) Hispanic889 (7.8)75 (9.7) Other/Unknown647 (5.7)49 (6.4)Marital Status, n (%)0.006 Married/Partner7470 (65.6)463 (60.1) Not Married/Partner3788 (33.3)300 (38.9) Unknown130 (1.1)8 (1.0)Educational Attainment, n (%)0.299 Less than High School929 (8.2)72 (9.3) High School Graduate2110 (18.5)145 (18.8) Some College4075 (35.8)290 (37.6) Bachelor's Degree or Higher3999 (35.1)243 (31.5) Unknown275 (2.4)21 (2.7)Household Income, n (%)0.008 \$25,000 or less1694 (14.9)150 (19.5) \$25,001 -- 50,0002477 (21.8)168 (21.8) \$50,001 -- 80,0001967 (17.3)122 (15.8) More than \$80,0002501 (22.0)169 (21.9) Unknown2749 (24.1)162 (21.0)Questionnaire Language, n (%)0.349 English11,077 (97.3)752 (97.5) Spanish280 (2.5)19 (2.5) Mandarin31 (0.3)0 (0.0)Region, n (%)0.941 Northern California5854 (51.4)395 (51.2) Southern California5534 (48.6)376 (48.8)Health BehaviorsPhysical Activity (past month), n (%)\< 0.001 None854 (7.5)86 (11.2) Low/Moderate7683 (67.5)532 (69.0) High2802 (24.6)149 (19.3) Unknown49 (0.4)4 (0.5)Cigarette Use (past year), n (%)0.002 Never4758 (41.8)303 (39.3) Former5759 (50.6)383 (49.7) Current624 (5.5)67 (8.7) Unknown247 (2.2)18 (2.3)Alcohol Use (past year), n (%)\< 0.001 Never2364 (20.8)105 (13.6) Former2245 (19.7)169 (21.9) Current6585 (57.8)484 (62.8) Unknown194 (1.7)13 (1.7)Self-Reported Health StatusPoor Physical Health (past month), n (%)\< 0.001 0 days6313 (55.4)320 (41.5) 1--7 days2156 (18.9)196 (25.4) 8--21 days816 (7.2)78 (10.1) 22--28 days80 (0.7)7 (0.9)  ≥ 29 days821 (7.2)74 (9.6) Unknown1202 (10.6)96 (12.5)Poor Mental Health (past month), n (%)\< 0.001 0 days7835 (68.8)400 (51.9) 1--7 days1401 (12.3)134 (17.4) 8--21 days593 (5.2)66 (8.6) 22--28 days66 (0.6)6 (0.8)  ≥ 29 days422 (3.7)50 (6.5) Unknown1071 (9.4)115 (14.9)Self-Rated Current Health, n (%)\< 0.001 Poor641 (5.6)59 (7.7) Fair2581 (22.7)228 (29.6) Good4561 (40.1)271 (35.2) Very Good2890 (25.4)168 (21.8) Excellent625 (5.5)36 (4.7) Unknown90 (0.8)9 (1.2)Sleep Affecting Daily Function (average), n (%)\< 0.001 Never2747 (24.1)145 (18.8) Rarely5283 (46.4)294 (38.1) 1--3 days/week1685 (14.8)154 (20.0) 4--6 days/week431 (3.8)44 (5.7) Almost every day1060 (9.3)126 (16.3) Unknown182 (1.6)8 (1.0)Memory Decline (past 2--3 years), n (%)\< 0.001 No5582 (49.0)294 (38.1) Yes4601 (40.4)397 (51.5) Unknown1205 (10.6)80 (10.4)Health Literacy, n (%)\< 0.001 Adequate8813 (77.4)536 (69.5) Inadequate2575 (22.6)235 (30.5)Medical HistoryLow-Dose Aspirin (past year; ≤100 mg/tablet), n (%)0.043 Did not use in the last 12 mo.6462 (56.7)404 (52.4) Did use in the last 12 mo.4488 (39.4)339 (44.0) Unknown438 (3.9)28 (3.6)Aspirin or Aspirin-Product (past year; ≥325 mg/tablet), n (%)0.240 Did not use in the last 12 mo.8431 (74.0)551 (71.5) Did use in the last 12 mo.2287 (20.1)174 (22.6) Unknown670 (5.9)46 (6.0)Body Mass Index (kg/m^2^), n (%)0.003  \< 253211 (28.2)191 (24.8) 25--303915 (34.4)254 (32.9)  ≥ 303492 (30.7)284 (36.8) Unknown770 (6.8)42 (5.5)Charlson Comorbidity Index (past year), n (%)0.124 03773 (33.1)255 (33.1) 12346 (20.6)175 (22.7) 21652 (14.5)124 (16.1)  ≥ 33617 (31.8)217 (28.2)CHADS~2~ Score (past five years), n (%)0.049 01849 (16.2)155 (20.1) 13959 (34.8)254 (32.9) 23782 (33.2)245 (31.8)  ≥ 31798 (15.8)117 (15.2)Coronary Heart Disease, n (%)1372 (12.1)92 (11.9)0.955Chronic Heart Failure, n (%)2457 (21.6)167 (21.7)0.964Dementia, n (%)288 (2.5)19 (2.5)\> 0.999Depression, n (%)2309 (20.3)191 (24.8)0.004Diabetes Mellitus, n (%)3096 (27.2)236 (30.6)0.041Hypertension, n (%)8961 (78.7)568 (73.7)0.001Ischemic Stroke or Transient Ischemic Attack, n (%)604 (5.3)39 (5.1)0.868^**†**^*p*-values based on chi-square, Fisher's exact and Wilcoxon signed-rank testsTable 3Adjusted odds ratios (95% confidence intervals) predicting medication non-adherence among 12,159 atrial fibrillation patientsAtrial Fibrillation Patients\
(n = 12,159)Socio-demographicsAge group, years  \< 65REF 65--740.68 (0.55, 0.83)^a^ 75--840.67 (0.53, 0.84)^a^  ≥ 850.86 (0.64, 1.16)Gender MaleREF Female0.97 (0.82, 1.15)Race/Ethnicity Non-Hispanic WhiteREF Non-Hispanic Black2.26 (1.73, 2.96)^a^ Non-Hispanic Asian/Pacific Islander1.59 (1.19, 2.13)^b^ Hispanic1.29 (0.98, 1.70) Other/Unknown1.24 (0.89, 1.71)Marital Status Married/PartnerREF Not Married/Partner1.24 (1.05, 1.48)^c^ Unknown1.24 (0.53, 2.90)Educational Attainment Less than High School1.07 (0.78, 1.48) High School Graduate1.01 (0.80, 1.29) Some College1.07 (0.88, 1.29) Bachelor's Degree or HigherREF Unknown1.35 (0.81, 2.27)Household Income \$25,000 or less1.17 (0.89, 1.55) \$25,001 -- 50,0001.00 (0.78, 1.28) \$50,001 -- 80,0000.94 (0.73, 1.21) More than \$80,000REF Unknown0.95 (0.74, 1.22)Health BehaviorsPhysical Activity (past month) None1.57 (1.16, 2.13)^b^ Low/Moderate1.13 (0.93, 1.38) HighREF Unknown1.81 (0.61, 5.37)Cigarette Use (past year) NeverREF Former0.98 (0.83, 1.16) Current1.24 (0.92, 1.67) Unknown1.00 (0.59, 1.70)Alcohol Use (past year) NeverREF Former1.69 (1.30, 2.20)^a^ Current1.91 (1.51, 2.43)^a^ Unknown1.36 (0.72, 2.58)Self-Reported Health StatusPoor Physical Health (past month) 0 daysREF 1--7 days1.43 (1.17, 1.75)^a^ 8--21 days1.28 (0.96, 1.72) 22--28 days1.08 (0.47, 2.46)  ≥ 29 days1.17 (0.84, 1.61) Unknown1.10 (0.83, 1.46)Poor Mental Health (past month) 0 daysREF 1--7 days1.31 (1.05, 1.63)^c^ 8--21 days1.35 (0.99, 1.83) 22--28 days0.96 (0.40, 2.34)  ≥ 29 days1.44 (1.00, 2.06)^c^ Unknown1.78 (1.38, 2.31)^a^Self-Rated Current Health Poor0.80 (0.49, 1.32) Fair0.94 (0.63, 1.40) Good0.79 (0.54, 1.15) Very Good0.94 (0.64, 1.37) ExcellentREF Unknown1.20 (0.54, 2.69)Sleep Affecting Daily Function (average) NeverREF Rarely1.01 (0.82, 1.25) 1--3 days/week1.35 (1.05, 1.73)^c^ 4--6 days/week1.46 (1.01, 2.11)^c^ Almost every day1.56 (1.19, 2.04)^b^ Unknown0.55 (0.24, 1.26)Memory Decline (past 2--3 years) NoREF Yes1.34 (1.13, 1.59)^a^ Unknown1.16 (0.89, 1.51)Health Literacy AdequateREF Inadequate1.32 (1.09, 1.60)^b^Medical HistoryBaby or Low-Dose Aspirin (past year; ≤100 mg/tablet) Did not use in the last 12 mo.REF Did use in the last 12 mo.1.21 (1.03, 1.42)^c^ Unknown1.01 (0.66, 1.56)Aspirin or Aspirin-Product (past year; ≥325 mg/tablet) Did not use in the last 12 mo.REF Did use in the last 12 mo.1.03 (0.85, 1.25) Unknown0.90 (0.64, 1.26)Body Mass Index (kg/m^2^)  \< 25REF 25--301.07 (0.87, 1.31)  ≥ 301.20 (0.96, 1.48) Unknown0.87 (0.61, 1.24)Charlson Comorbidity Index (past year) 0REF 11.06 (0.86, 1.31) 21.08 (0.84, 1.38)  ≥ 30.77 (0.60, 1.00)^c^Coronary Heart Disease NoREF Yes1.01 (0.79, 1.28)Chronic Heart Failure NoREF Yes0.98 (0.80, 1.20)Dementia NoREF Yes0.76 (0.46, 1.24)Depression NoREF Yes0.96 (0.80, 1.16)Diabetes Mellitus NoREF Yes1.22 (1.01, 1.48)^c^Hypertension NoREF Yes0.72 (0.60, 0.87)^a^Ischemic Stroke or Transient Ischemic Attack NoREF Yes0.96 (0.68, 1.35)^a^ \< 0.001^b^ \< 0.01^c^ \< 0.05

Discussion {#Sec9}
==========

Among a large, ethnically-diverse sample of adults with incident AF receiving medical care within an integrated healthcare delivery system, we classified 6.3% as being not optimally adherent to prescribed medications per self-report. Patients were more likely to be non-adherent to their prescribed medications if they were a racial/ethnic minority versus non-Hispanic white, not married/with partner, physical inactive, used alcohol, had any days of self-reported poor physical health, mental health and/or sleep quality in the past 30 days versus 0 days, had memory decline, inadequate health literacy, low-dose aspirin use and/or diabetes mellitus. Whereas, patients who were of older age (65--84 years versus \< 65 years of age), had a Charlson Comorbidity Index score ≥ 3 versus 0 and had hypertension were less likely to be non-adherent.

Several studies have estimated one-year non-adherence rates to oral anticoagulants among AF patients to be 3--28% based on the type of oral anticoagulant prescribed \[[@CR11]--[@CR13], [@CR43]\]. Although our study assessed general medication adherence, which included assessment of both medication adherence to AF-specific treatment and any medication used to treat comorbidities, our medication non-adherence rate within our full AF cohort (6.3%) was on the lower end of what has been previously estimated in an AF population. More broadly, it has been shown that self-reported medication adherence to cardiovascular disease medications is less than 40% \[[@CR44]\] and in an elderly population with a range of chronic illnesses only 45% had good medication adherence \[[@CR45]\]. Our finding of only 6.3% medication non-adherence may be due, in part, to our cohort receiving care within an integrated healthcare delivery system that emphasizes coordination of care across different providers and clinical setting through a single EHR, as opposed to the more fragmented care seen in other types of healthcare delivery systems \[[@CR46], [@CR47]\]. Additionally, our assessment of medication adherence was based on self-report. This may have introduced some recall, social desirability and/or interviewer bias, leading to an over-estimate of the patient's actual medication adherence \[[@CR48]\]. Nonetheless, using this brief self-reported measure of medication adherence increased our ability to capture adherence information from a larger population (in our case 12,159 atrial fibrillation patients) due to the ease and cost-effectiveness of implementation in a clinical setting \[[@CR49]\]. Additionally, self-reported medication adherence measures may also have the benefit of demonstrating high specificity in capturing people who are truly non-adherent \[[@CR48], [@CR49]\]. This was particularly valuable in our analyses, where we aimed to better understand population-level patient factors that may be associated with medication non-adherence in patients with atrial fibrillation. Self-reported adherence measures have also been shown to correlate well with adherence captured by pill counts and other monitoring devices \[[@CR50]\], as well as with pharmacy dispensing records \[[@CR51]\].

Results from the univariate analyses showed that patients who self-reported non-adherence to prescribed medications generally reported worse health indicators, as well as, factors related to low socio-economic status (racial/ethnic minority, being unmarried, lower household income, physical inactivity, BMI ≥30, alcohol and cigarette use, poor physical, mental and current health, decreased sleep quality, memory decline, inadequate health literacy and both depression and diabetes mellitus) which are similar to those factors that have been reported with non-adherence in other chronic conditions \[[@CR52]\]. Many of these risk factors for medication non-adherence may also be preventable and/or modifiable. Physical inactivity and alcohol use, although most likely not directly related to medication adherence, can lead to poor physical health, mental health and sleep quality. These later three factors have all been associated with medication non-adherence across populations \[[@CR53], [@CR54]\]. Poor health literacy, on the other hand, may be both modifiable and preventable. It is also one of the most common problems associated with medication non-adherence \[[@CR55]\]. Additionally, our study found that non-adherent patients were less likely to have hypertension, but more likely to report low-dose aspirin use in the last year and have CHADS~2~ score of 0 when compared to patients who were adherent. The finding that patients who had hypertension were more likely to be adherent to their medication(s) is most likely due to the success of the Kaiser Permanente Hypertension Control Program \[[@CR56]\]. From 2001 to 2013, hypertension control within KPNC increased from 44 to 90% \[[@CR57]\]. One aspect of this program encouraged single pill combination therapy --- combining multiple drugs into one pill. This strategy improved adherence, lowered patient costs and improved blood pressure control. Due to the program's success, Kaiser Permanente Southern California also implemented these strategies into their region. Thus, many, if not all, patients included in our study were recipients of this program.

In our multivariable regression analysis, results paralleled those from the univariate associations. Of note, however, was the finding that higher CCI score (≥3) was linked to lower adjusted odds of being non-adherent compared to a CCI score of 0. These results may reflect the impact of increased contact with healthcare providers, which can improve medication adherence accountability \[[@CR46], [@CR47]\].

Considering these findings, we also acknowledge that the cross-sectional and observational nature of these data precluded us from assessing longitudinal trends in medication adherence among our patients with incident AF. Additionally, we were unable to assess polypharmacy for inclusion in our adjusted models. Thus, it may be that our low non-adherence rate was influenced by the relatively few prescriptions prescribed per patient. We were also unable to measure time since diagnosis to questionnaire completion. As adherence rates to AF-specific medications have been shown to decline with time, it may be that many of our patients completed the questionnaire soon after being diagnosed with atrial fibrillation. Thus, adherence for those patients could have been misleadingly high. However, a strength of our study was that we had access to a large, socio-demographically diverse population of validated incident diagnosed AF patients. This allowed for the detailed investigation into the relationships between a wide range patient factors and medication adherence status within a highly representative population of AF patients.

Conclusions {#Sec10}
===========

In an ethnically-diverse cohort of AF patients, we identified multiple possible risk factors for medication non-adherence. These include selected socio-demographic characteristics, lifestyle factors, self-reported poor physical health, mental health and/or sleep quality, having memory decline, inadequate health literacy, using low-dose aspirin, having diabetes mellitus and a higher comorbidity burden. This has broad implications for both patients and providers when managing care for patients with AF, where maximizing the benefit from AF medication and treatment for any existing comorbidities involves understanding the patient factors associated with medication non-adherence. Additionally, by finding ways to intervene on those risk factors that may be preventable and/or modifiable may improve overall medication adherence and bring awareness to those patients at highest risk for non-adherence.
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